U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07450170) titled 'A Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in China' on Feb. 27.
Brief Summary: The aim of this study is to characterize the real-world treatment patterns of omalizumab among adult patients with chronic urticaria in China using data from a regional electronic healthcare (rEHR) database. This includes assessing the frequency and proportion of prescriptions across different dosages of omalizumab in real-world clinical practice.
Study Start Date: March 06
Study Type: OBSERVATIONAL
Condition:
Chronic Urticaria
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novartis Pharmaceuticals
Published...